---
$id: https://graph.org.ai/products/commodity/51121925
$type: Product
source: UNSPSC
code: "51121925"
title: "Ramnodigin"
class: "51121900"
classTitle: "Drugs used for congestive heart failure"
family: "51120000"
familyTitle: "Antiarrythmics and antianginals and cardioplegics and drugs for heart failure"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ramnodigin

**UNSPSC Code**: 51121925
**Class**: [Drugs used for congestive heart failure](Drugs used for congestive heart failure.mdx)
**Family**: [Antiarrythmics and antianginals and cardioplegics and drugs for heart failure](../Antiarrythmics and antianginals and cardioplegics and drugs for heart failure.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a cardiotonic agent with the molecular formula C29H44O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Z8SRY7BR30, chemically known as 14-hydroxy-3beta-((2,3,6-trihydroxy-alpha-l-erythro-hexopyranosyl)oxy)-5beta-card-20(22)-enolide but generally known as ramnodigin, which bears US NIH Compound Identifier 3052773. European Medicines Agency schedules Ramnodigin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10251MIG. The term RAMNODIGIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). RAMNODIGIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ramnodigin under HS 29389090 and SITC 54161. As of Q4 2014, RAMNODIGIN remains the US FDA Preferred Term for this commodity. Ramnodigin bears US NLM identifiers UMLS ID C2699004 and NCI Concept Code C76589. SMILES: OC12C3C(C4(C(CC3)CC(OC3OC(C(O)CC3)C)CC4)C)CCC1(C(CC2)C1=CC(=O)OC1)C.

